Brief: Medincell Pharma Names Richard Malamut As Chief Medical Officer
May 9 (Reuters) - Medincell SA MEDCL.PA :
* MEDINCELL: US PHARMA DEVELOPMENT EXPERT RICHARD MALAMUT,
MD
BECOMES CHIEF MEDICAL OFFICER
* HE JOINS MEDINCELL AS PART OF NEWLY CREATED US SUBSIDIARY
* HE IS A FORMER MEMBER OF MEDINCELL'S MEDICAL ADVISORY
BOARD AND
MEDINCELL'S BOARD OF DIRECTORS' OBSERVER
* HE OVERSAW EARLY CLINICAL STRATEGY OF MDC-IRM AT TEVA
(2013-2016)
Source text for Eikon: ID:nBw1BJHxXa
Further company coverage: MEDCL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Medincell SA
See all newsBrief: Medincell Has Secured An Additional EUR 13.8 Million In Non-Dilutive Financing From Leading European Commercial Banks And Bpifrance
Teva gains after FDA approves monthly schizophrenia injection
Corrected: UPDATE 1-Teva wins FDA approval for monthly schizophrenia injection Weltruza
Teva wins FDA approval for monthly schizophrenia injection Weltruza
Brief: Medincell Announces Temporary Shares Trading Suspension On Euronext Paris